Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2026-02-03 @ 12:42 AM
Study NCT ID:
NCT00244933
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2005-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2597
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |